1. Targeting Macroautophagy as a Therapeutic Opportunity to Treat Parkinson’s Disease
   Irene Sanchez-Mirasierra et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
2. Inhibition of long non-coding RNA HOXA11-AS against neuroinflammation in Parkinson's disease model via targeting miR-124-3p mediated FSTL1/NF-κB axis
   Hua Cao et al, 2021, Aging CrossRef
3. Key Mechanisms and Potential Targets of the NLRP3 Inflammasome in Neurodegenerative Diseases
   Yadi Guan et al, 2020, Frontiers in Integrative Neuroscience CrossRef
4. Neurodegeneration and Neuroinflammation in Parkinson’s Disease: a Self-Sustained Loop
   G. Arena et al, 2022, Current Neurology and Neuroscience Reports CrossRef
5. Increased pyroptosis activation in white matter microglia is associated with neuronal loss in ALS motor cortex
   Evelien Van Schoor et al, 2022, Acta Neuropathologica CrossRef
6. Neurodegenerative Disease and the NLRP3 Inflammasome
   Jonathan A. Holbrook et al, 2021, Frontiers in Pharmacology CrossRef
7. Evidence of Inflammation in Parkinson’s Disease and Its Contribution to Synucleinopathy
   Thuy Thi Lai et al, 2022, Journal of Movement Disorders CrossRef
8. A novel sorbicillinoid compound as a potent anti‐inflammation agent through inducing NLRP3 protein degradation
   Fangfang Wang et al, 2023, British Journal of Pharmacology CrossRef
9. Mechanistic Insight from Preclinical Models of Parkinson’s Disease Could Help Redirect Clinical Trial Efforts in GDNF Therapy
   Karen M. Delgado-Minjares et al, 2021, International Journal of Molecular Sciences CrossRef
10. The Potential of NLRP3 Inflammasome as a Therapeutic Target in Neurological Diseases
    Wenfang He et al, 2023, Molecular Neurobiology CrossRef
11. The Role of NLRP3 Inflammasome in Alzheimer’s Disease and Potential Therapeutic Targets
    Tao Liang et al, 2022, Frontiers in Pharmacology CrossRef
12. The Dichotomous Role of Inflammation in the CNS: A Mitochondrial Point of View
    Bianca Vezzani et al, 2020, Biomolecules CrossRef
13. Artemisinin attenuated oxidative stress and apoptosis by inhibiting autophagy in MPP+-treated SH-SY5Y cells
    Junqiang Yan et al, 2021, Journal of Biological Research-Thessaloniki CrossRef
14. Contribution of Mitochondrial Dysfunction Combined with NLRP3 Inflammasome Activation in Selected Neurodegenerative Diseases
    Anna Litwiniuk et al, 2021, Pharmaceuticals CrossRef
15. Pivotal Role of Fyn Kinase in Parkinson’s Disease and Levodopa-Induced Dyskinesia: a Novel Therapeutic Target?
    Efthalia Angelopoulou et al, 2021, Molecular Neurobiology CrossRef
16. Immunomodulatory Effects of Dopamine in Inflammatory Diseases
    Yifei Feng et al, 2021, Frontiers in Immunology CrossRef
17. Modulating neuroinflammation in neurodegeneration-related dementia: can microglial toll-like receptors pull the plug?
    Rohit Kumar Tiwari et al, 2021, Metabolic Brain Disease CrossRef
18. Proteostasis Disturbances and Inflammation in Neurodegenerative Diseases
    Tuuli-Maria Sonninen et al, 2020, Cells CrossRef
19. The NLRP3 Inflammasome Pathway: A Review of Mechanisms and Inhibitors for the Treatment of Inflammatory Diseases
    Hallie M. Blevins et al, 2022, Frontiers in Aging Neuroscience CrossRef
20. Emerging targets signaling for inflammation in Parkinson’s disease drug discovery
    Rhema Chandan Khairnar et al, 2022, Metabolic Brain Disease CrossRef
21. In vitro methods in autophagy research: Applications in neurodegenerative diseases and mood disorders
    Dalinda Isabel Sánchez-Vidaña et al, 2023, Frontiers in Molecular Neuroscience CrossRef